Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 4, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oyster Point Pharma, Inc.
| -77.46K |
$11.70 |
—
| -100.00% |
0
|
Jan 29 - Jan 3
| |||||||
Oyster Point Pharma, Inc.
| -3.26K |
$11.20 | -$36,489.60 | -4.19% | 74.46K |
Dec 1
| |||||||
Oyster Point Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 6
| |||||||
Oyster Point Pharma, Inc.
| 19.5K |
—
|
—
| +33.49% | 77.72K |
Jan 9
| |||||||
Oyster Point Pharma, Inc.
| 8.59K |
$11.51 | $98,870.90 | +17.31% | 58.22K |
Nov 1
| |||||||
Oyster Point Pharma, Inc.
| 7.5K |
$11.51 | $86,325.00 | +17.80% | 49.63K |
Sep 2
| |||||||
Oyster Point Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 26
| |||||||
Oyster Point Pharma, Inc.
| 7.5K |
$11.51 | $86,325.00 | +21.66% | 42.13K |
Jul 28
| |||||||
Oyster Point Pharma, Inc.
| 9.11K |
$11.51 | $104,844.59 | +35.69% | 34.63K |
Feb 24
| |||||||
Oyster Point Pharma, Inc.
| 11.22K |
—
|
—
| +78.48% | 25.52K |
Jan 29
| |||||||
Oyster Point Pharma, Inc.
| 4K |
$11.51 | $46,040.00 | +38.83% | 14.3K |
Sep 25
| |||||||
Oyster Point Pharma, Inc.
| 4K |
$11.51 | $46,040.00 | +63.49% | 10.3K |
Aug 11
| |||||||
Oyster Point Pharma, Inc.
| 4K |
$11.51 | $46,040.00 |
∞
| 4K |
Aug 11
| |||||||
Oyster Point Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 3
| |||||||
Oyster Point Pharma, Inc.
| 6.3K |
$16.00 | $100,800.00 |
∞
| 6.3K |
Nov 4
| |||||||
Oyster Point Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||